Disc Medicine, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Disc Medicine, Inc. (IRON), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are IRON insiders buying or selling?
Disc Medicine, Inc. insiders reported 10 open-market buys ($34.9M) and 101 sells ($358.4M) across 111 Form 4 filings — a net selling position of $323.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 14, 2026)
Insider sentiment
Net sellingNet insider flow of $323.4M in net selling.
Recent IRON insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | John D Quisel | Chief Executive Officer | Sale | 33.0K | $74.96 | $2.5M |
| Jul 9, 2026 | Jonathan Yen-Wen Yu | Chief Operating Officer | Sale | 100 | $82.50 | $8.3K |
| Jun 30, 2026 | Rahul Khara | Chief Legal Officer | Sale | 2.5K | $75.00 | $187.5K |
| Jun 30, 2026 | Jonathan Yen-Wen Yu | Chief Operating Officer | Sale | 300 | $72.50 | $21.8K |
| Jun 25, 2026 | Jonathan Yen-Wen Yu | Chief Operating Officer | Sale | 9.7K | $72.66 | $704.8K |
| Jun 23, 2026 | Rahul Khara | Chief Legal Officer | Sale | 7.5K | $70.22 | $526.7K |
| Jun 23, 2026 | John D Quisel | Chief Executive Officer | Sale | 34.0K | $70.21 | $2.4M |
| Jun 18, 2026 | Jonathan Yen-Wen Yu | Chief Operating Officer | Sale | 18.6K | $69.19 | $1.3M |
| Apr 15, 2026 | William Jacob Savage | Chief Medical Officer | Sale | 5.7K | $66.38 | $380.4K |
| Apr 15, 2026 | Jean M. Franchi | Chief Financial Officer | Sale | 6.7K | $69.23 | $460.8K |
| Mar 4, 2026 | William Jacob Savage | Chief Medical Officer | Sale | 7.4K | $65.88 | $486.1K |
| Feb 27, 2026 | Jean M. Franchi | Chief Financial Officer | Sale | 353 | $69.06 | $24.4K |
| Feb 19, 2026 | Jean M. Franchi | Chief Financial Officer | Sale | 11.2K | $64.51 | $719.7K |
| Feb 18, 2026 | Rahul Khara | Chief Legal Officer | Sale | 2.9K | $62.86 | $179.3K |
| Feb 18, 2026 | Pamela Stephenson | Chief Commercial Officer | Sale | 5.5K | $62.86 | $347.7K |
| Feb 18, 2026 | William Jacob Savage | Chief Medical Officer | Sale | 3.3K | $62.86 | $204.7K |
| Feb 18, 2026 | Jonathan Yen-Wen Yu | Chief Operating Officer | Sale | 3.2K | $62.86 | $203.1K |
| Feb 18, 2026 | John D Quisel | Chief Executive Officer | Sale | 13.3K | $62.86 | $833.8K |
| Jan 21, 2026 | Rahul Khara | Chief Legal Officer | Sale | 1.0K | $69.74 | $69.7K |
| Jan 6, 2026 | Rahul Khara | Chief Legal Officer | Sale | 6.5K | $78.69 | $511.5K |
| Dec 18, 2025 | Kevin Bitterman | Director | Sale | 754 | $91.47 | $69.0K |
| Dec 15, 2025 | John D Quisel | Chief Executive Officer | Sale | 40.0K | $93.05 | $3.7M |
| Nov 14, 2025 | Jonathan Yen-Wen Yu | Chief Operating Officer | Sale | 30.0K | $84.70 | $2.5M |
| Oct 24, 2025 | Len Blavatnik | 10% Owner | Sale | 744.0K | $80.47 | $59.9M |
| Oct 17, 2025 | Kevin Bitterman | Director | Sale | 93.6K | $85.97 | $8.0M |
Showing the 25 most recent of 111 Form 4 filings for Disc Medicine, Inc..
Most active IRON insiders
- Kevin Bitterman15 filings
- William Jacob Savage14 filings
- Rahul Khara11 filings
- John D Quisel10 filings
- William Richard White10 filings
Ask anything about IRON insider activity
Use Trabud's AI agent to query Disc Medicine, Inc.'s Form 4 history in plain English — "Show me IRON CEO purchases this year" or compare it against any other ticker.
Open the AI agentIRON insider trading FAQ
Are Disc Medicine, Inc. insiders buying or selling?
Across 111 SEC Form 4 filings, Disc Medicine, Inc. (IRON) insiders reported 10 open-market purchases totaling $34.9M and 101 sales totaling $358.4M. That is a net selling position of $323.4M.
How many insiders trade IRON stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Disc Medicine, Inc.. The most recent filing was accepted on Jul 14, 2026.
Where does Trabud get IRON insider trading data?
All IRON insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.